The review further addresses exercise-induced FoxO modulation in metabolic syndrome, insulin sensitivity, neurodegeneration, cardiovascular diseases, inflammation, and cancer, underlining the broad systemic impact of this signaling pathway. This evidence concerns the gene INS and metabolic syndrome.